PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Nationwide study suggests that water treatment methods may impact the risk of legionnaires’ disease

Higher rates of disease are seen in zip codes served by water treatment plants that use chlorine as the primary disinfectant

2025-12-09
(Press-News.org) FOR IMMEDIATE RELEASE 

EMBARGOED UNTIL DECEMBER 9, 2025 

Nationwide Study Suggests that Water Treatment Methods May Impact the Risk of Legionnaires’ Disease 

Higher rates of disease are seen in zip codes served by water treatment plants that use chlorine as the primary disinfectant 

Washington, D.C., December 9, 2025 – Preliminary results of a nationwide study suggest that the disinfectant used to treat water before it is distributed through pipes may impact the incidence of Legionnaire’s disease in certain parts of the country. The findings will be presented Dec. 9 at the annual meeting of the Society for Risk Analysis in Washington, D.C.  

Waterborne diseases – caused by bacteria, viruses, and parasites – affect more than 7 million people in the United States every year, according to the Centers for Disease Control (CDC). One of them is Legionnaires’ disease, a potentially severe pneumonia. It is caused by the bacterium Legionella, which grows in the pipes of water systems, where it can be spread through aerosolized droplets from sources such as showerheads, decorative fountains, or building cooling towers.  

Researchers conducted an epidemiological study comparing historical data on Legionnaire’s disease in the United States with 25 water utilities’ treatment attributes (representing all 10 EPA regions). The rates of Legionnaires’ disease among residents served by the utilities in the study ranged from no reported cases to an average of 8.36 cases per 100,000 people.  

Preliminary findings show that: 

There are higher rates of Legionnaires' Disease in zip codes served by water treatment plants that use chlorine as the primary disinfectant, rather than monochloramine. 

There are also higher rates of disease when plants use chlorine as the secondary disinfectant, rather than using chlorine as the primary disinfectant and monochloramine as the secondary disinfectant.  

There was a seasonality result in the data, with Legionnaires' disease occurring less frequently in the winter months and most frequently in the summer months.  

These preliminary results back up data from previous studies of individual buildings. (For example, previous research has found that in healthcare facilities where the water is treated with monochloramine, there is a lower prevalence of Legionnaires’’s disease.) The risk for Legionnaires' disease is higher for people with weakened immune systems, older adults, smokers, and those with chronic lung or kidney diseases. 

“Legionella is extremely challenging to treat and manage in a building’s plumbing system once it establishes a niche,” says Alexis Mraz, author of the study and an assistant professor of public health at The College of New Jersey. “It is important to think about the whole life of the water, from treatment to tap, when we consider how to best manage this pathogen and lower the incidence of Legionnaires’disease.”  

### 

EDITORS NOTE:  

This research will be presented on December 10 at 8:00 EST at the Society for Risk Analysis (SRA) Annual Conference at the Downtown Westin Hotel in Washington, D.C. SRA Annual Conference welcomes press attendance. Please contact Emma Scott at emma@bigvoicecomm.com to register. 

 

About Society for Risk Analysis 

The Society for Risk Analysis (SRA) is a multidisciplinary, global organization dedicated to advancing the science and practice of risk analysis. Founded in 1980, SRA brings together researchers, practitioners, and policymakers from diverse fields including engineering, public health, environmental science, economics, and decision theory. The Society fosters collaboration and communication on risk assessment, management, and communication to inform decision-making and protect public well-being. SRA supports a wide range of scholarly activities, publications, and conferences. Learn more at www.sra.org. 

Media Contact: 

Emma Scott 

Media Relations Specialist 

Emma@bigvoicecomm.com 

(740)632-0965 

END



ELSE PRESS RELEASES FROM THIS DATE:

Oyster larvae on drugs move slowly and are stressed

2025-12-09
FOR IMMEDIATE RELEASE  EMBARGOED UNTIL DECEMBER 9, 2025  Oyster Larvae on Drugs Move Slowly and Are Stressed  Study finds that exposure to addictive drugs like fentanyl and ketamine affect the behavior and survival rates of oyster larvae   Washington, D.C., December 9, 2025 – The discharge and prevalence of psychoactive drugs in surface waters has raised concerns about potential risks to ecosystems and public health. Yet there is limited information on the ecotoxicity of these compounds in marine environments and aquaculture.  A study presented on Dec. 9 at the annual meeting of the Society for Risk Analysis in ...

Targeting a specific brain circuit may help prevent opioid relapse, WSU study finds

2025-12-09
PULLMAN, Wash. -- Washington State University researchers have discovered how a neural circuit – or a connection between two brain regions – drives relapse after opioid use, a finding that could lead to more effective treatments for opioid use disorders. In a study published in the Journal of Neuroscience, researchers in the Department of Integrative Physiology and Neuroscience at WSU’s College of Veterinary Medicine used a preclinical model to model opioid use in humans and found that reducing the activity within a specific neuronal ...

Tec-Dara combination offers substantial improvement over standard second-line therapies for relapsed or refractory multiple myeloma

2025-12-09
(ORLANDO, Dec. 9, 2025) Patients with relapsed or refractory (R/R) multiple myeloma who received a combination of teclistamab, a bispecific monoclonal antibody, and daratumumab, a CD38-directed monoclonal antibody, were 83% more likely to be alive without disease progression compared with those who received standard second-line therapies at a median of nearly 35 months of follow-up, according to the results of a new trial presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. The ...

Improving treatment for an autoimmune bleeding condition

2025-12-09
PHILADELPHIA – More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal antibody ianalumab for primary immune thrombocytopenia (ITP), an autoimmune disorder that can cause life-threatening bleeding, were able to maintain safe platelet counts without serious bleeding episodes for at least one year. The results were published today in the New England Journal of Medicine, by researchers from the Perelman School of Medicine at the University of Pennsylvania, and presented by collaborators at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition Orlando, Florida (LBA-2). ITP is an autoimmune condition where ...

Drug reduced need for blood transfusions during hospitalization for non-cardiac surgery

2025-12-09
(ORLANDO, Dec. 9, 2025) –– When hospitals were randomly assigned to treat patients undergoing higher-risk non-cardiac surgery with tranexamic acid (TXA) or a placebo, patients who received TXA needed significantly fewer blood transfusions and saw no increase in potentially life-threatening blood clots (thrombosis) after 90 days of follow-up, according to research presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. “Our findings confirm that TXA reduces the need for blood transfusion in patients ...

Novel agent ianalumab added to standard therapy extends time to treatment failure in patients with previously treated immune thrombocytopenia

2025-12-09
(ORLANDO, Dec. 9, 2025) Patients with immune thrombocytopenia (ITP) who received a first-in-class investigational drug in addition to standard therapy went longer without a bleeding episode that needed urgent treatment or needing another treatment for their ITP, compared with patients who received a placebo in addition to standard therapy. The study is the first to test a novel drug for ITP early in the disease course and was presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. “In patients for whom first-line therapy had stopped working, treatment ...

Pirtobrutinib outperforms bendamustine plus rituximab for previously untreated CLL/SLL

2025-12-09
(ORLANDO, Dec. 9, 2025) – In a new trial, the Bruton tyrosine kinase (BTK) inhibitor pirtobrutinib increased the rate of survival without disease progression and was well tolerated with a more favorable safety profile when compared with bendamustine plus rituximab (BR) in patients with previously untreated chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). The data were presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. “We were able to prove that pirtobrutinib is an excellent drug both in terms of efficacy and tolerance,” ...

Online tracking and privacy on hospital websites

2025-12-09
Researchers find that tracking pixels—small pieces of embedded code that can transmit user data to third parties—significantly increase data breach risk on hospital websites. Hilal Atasoy and colleagues analyzed 12 years of archived website data from 1,201 large US hospitals between 2012 and 2023, examining the adoption of pixel tracking and their relationship to data breaches. The authors found pixel tracking in 66% of hospital-year observations, despite stringent privacy regulations. Hospitals using third-party pixels experienced at least a 1.4 percentage point increase in breach probability, representing a 46% ...

A freely available tool to document wartime destruction

2025-12-09
Researchers develop a method to detect the destruction of buildings using freely available satellite radar imagery. Daniel Racek and colleagues’ algorithm analyzes publicly available Sentinel-1 synthetic aperture radar images from the European Space Agency to identify destroyed buildings in conflict zones. The method statistically assesses the visual similarity of locations over time, enabling detection of destruction from a single satellite image every 12 days, without requiring labeled training data or expensive proprietary imagery. Unlike optical ...

Residential solar panels can raise electricity rates

2025-12-09
A modeling study shows how under some conditions, increasing numbers of households with rooftop solar panels can lead to higher rates for those without their own solar system. When utility customers cancel their accounts after switching to residential solar panels, the utility must spread their fixed costs around to a smaller number of remaining customers, which can lead to rate increases. Charles Sims and colleagues studied how this pecuniary externality affects different income groups using agent-based computational economic modeling of the Tennessee Valley Authority (TVA), an area with some of the highest poverty rates in the United States. The authors asked 2,307 TVA residential customers ...

LAST 30 PRESS RELEASES:

An assessment of the antidepressant potential of deramciclane in two animal tests

Pitt and UPMC study finds epigenetic signature of pediatric traumatic brain injury, paves way for precision recovery tools

Brain discovery opens door to earlier detection of metabolic syndrome in women

SwRI-led study provides insight into oscillations in solar flares

Announcing the third cohort of the Hevolution/AFAR new investigator awards in aging biology and geroscience research

GeoFlame VISION: Using AI and satellite imagery to predict future wildfire risk

Nationwide study suggests that water treatment methods may impact the risk of legionnaires’ disease

Oyster larvae on drugs move slowly and are stressed

Targeting a specific brain circuit may help prevent opioid relapse, WSU study finds

Tec-Dara combination offers substantial improvement over standard second-line therapies for relapsed or refractory multiple myeloma

Improving treatment for an autoimmune bleeding condition

Drug reduced need for blood transfusions during hospitalization for non-cardiac surgery

Novel agent ianalumab added to standard therapy extends time to treatment failure in patients with previously treated immune thrombocytopenia

Pirtobrutinib outperforms bendamustine plus rituximab for previously untreated CLL/SLL

Online tracking and privacy on hospital websites

A freely available tool to document wartime destruction

Residential solar panels can raise electricity rates

Scientists use synthetic platelets as ‘Trojan horse’ drug-delivery system

Cooperative Intermolecular Interactions Regulate Supramolecular Polymer Assembly

Korea University researchers develop ultrasensitive method to detect low-frequency cancer mutations

First patient enrolled in GOG-3133/ FRAmework-01 phase 3 study evaluating sofetabart mipitecan (LY4170156), a novel ADC targeting folate receptor alpha (FRα), in recurrent ovarian cancer

Two Hebrew University researchers win prestigious ERC consolidator grants

ERC grant helps to quantify the impact of anthropogenic air pollution particles on climate

Exercise might help improve mobility during aging

New online tool detects drug exposure directly from patient samples

Learn the surprising culprit limiting the abundance of Earth’s largest land animals

Study reveals new ways the brain regulates communication between neurons

Research reveals new hybrid state of matter where solids meet liquids

Researchers develop a new computational tool to understand how genetic interactions impact human traits

Elephants, giraffes and rhinos go where the salt is

[Press-News.org] Nationwide study suggests that water treatment methods may impact the risk of legionnaires’ disease
Higher rates of disease are seen in zip codes served by water treatment plants that use chlorine as the primary disinfectant